Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human hepatocarcinoma-intestine-pancreas / pancreatic associated protein

EU orphan designation number: EU/3/08/611   
Active ingredient: Recombinant human hepatocarcinoma-intestine-pancreas / pancreatic associated protein
Indication: Treatment of acute liver failure
Sponsor: Alfact Innovation SAS
320 rue Saint Honoré, F-75001 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2009 Centralised Orphan - Designation EMEA/OD/085/08 (2009)1052 of 11/02/2009